Resultados de la búsqueda 981-990 of 10598 for autoimmune hepatitis
Hepatitis alcohólica (hepatitis relacionada con el alcohol) · Hepatitis autoinmune · Hepatitis C · Hepatitis tóxica · Hepatitis B · Insuficiencia hepática aguda ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
The purpose of this study is to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
Trasplante de hígado, Colangitis esclerosante primaria, Hepatitis C, Hepatitis B, carcinoma hepatocelular, Cirrosis bil...iar primaria, Hígado graso no ...
Rochester, Minn. The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Engineering stem cells to treat liver disease Nov. 11, 2023, 12:00 p.m. CDT; Science Saturday: Researchers elucidate details about the role of inflammation ...
Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?